A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer - PubMed (original) (raw)
doi: 10.1038/ng892. Epub 2002 May 6.
Affiliations
- PMID: 11992124
- DOI: 10.1038/ng892
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
Hiromu Suzuki et al. Nat Genet. 2002 Jun.
Abstract
Aberrant hypermethylation of gene promoters is a major mechanism associated with inactivation of tumor-suppressor genes in cancer. We previously showed this transcriptional silencing to be mediated by both methylation and histone deacetylase activity, with methylation being dominant. Here, we have used cDNA microarray analysis to screen for genes that are epigenetically silenced in human colorectal cancer. By screening over 10,000 genes, we show that our approach can identify a substantial number of genes with promoter hypermethylation in a given cancer; these are distinct from genes with unmethylated promoters, for which increased expression is produced by histone deacetylase inhibition alone. Many of the hypermethylated genes we identified have high potential for roles in tumorigenesis by virtue of their predicted function and chromosome position. We also identified a group of genes that are preferentially hypermethylated in colorectal cancer and gastric cancer. One of these genes, SFRP1, belongs to a gene family; we show that hypermethylation of four genes in this family occurs very frequently in colorectal cancer, providing for (i) a unique potential mechanism for loss of tumor-suppressor gene function and (ii) construction of a molecular marker panel that could detect virtually all colorectal cancer.
Comment in
- An epigenetic approach for finding tumor suppressors.
Jones PA. Jones PA. Cell Cycle. 2003 Jan-Feb;2(1):25-6. doi: 10.4161/cc.2.1.251. Cell Cycle. 2003. PMID: 12695681 No abstract available.
Similar articles
- Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
Ogawa K, Utsunomiya T, Mimori K, Yamashita K, Okamoto M, Tanaka F, Inoue H, Ikeda Y, Saku M, Murayama S, Mori M. Ogawa K, et al. Int J Oncol. 2005 Aug;27(2):417-26. Int J Oncol. 2005. PMID: 16010423 - Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE, Bachman KE, Myöhänen S, Herman JG, Baylin SB. Cameron EE, et al. Nat Genet. 1999 Jan;21(1):103-7. doi: 10.1038/5047. Nat Genet. 1999. PMID: 9916800 - ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.
Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA. Lind GE, et al. Cell Oncol. 2006;28(5-6):259-72. doi: 10.1155/2006/949506. Cell Oncol. 2006. PMID: 17167179 Free PMC article. - Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K, Issa JP. Konishi K, et al. Cancer J. 2007 Jan-Feb;13(1):49-55. doi: 10.1097/PPO.0b013e31803c72fe. Cancer J. 2007. PMID: 17464246 Review. - CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M. Esteller M. Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600. Oncogene. 2002. PMID: 12154405 Review.
Cited by
- Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line.
Demirkiran N, Aydin B, Pehlivan M, Yuce Z, Sercan HO. Demirkiran N, et al. Med Oncol. 2024 Apr 9;41(5):109. doi: 10.1007/s12032-024-02336-2. Med Oncol. 2024. PMID: 38592567 - Severe induction of aberrant DNA methylation by nodular gastritis in adults.
Sasaki A, Takeshima H, Yamashita S, Ichita C, Kawachi J, Naito W, Ohashi Y, Takeuchi C, Fukuda M, Furuichi Y, Yamamichi N, Ando T, Kobara H, Kotera T, Itoi T, Sumida C, Hamada A, Koizumi K, Ushijima T. Sasaki A, et al. J Gastroenterol. 2024 Jun;59(6):442-456. doi: 10.1007/s00535-024-02094-y. Epub 2024 Mar 19. J Gastroenterol. 2024. PMID: 38499886 - Highly expressed miR-144-3p promotes the proliferation, migration and invasion of colon carcinoma cells by activating the Wnt/β-catenin signaling pathway through targeting SFRP1.
Lai C, He N, Zeng J, Long C, Shi M, Li J, Ma S, Xiong Y, Liang X. Lai C, et al. J Cancer. 2023 Sep 25;14(16):3117-3129. doi: 10.7150/jca.87792. eCollection 2023. J Cancer. 2023. PMID: 37859826 Free PMC article. - Human Neuralized is a novel tumour suppressor targeting Wnt/β-catenin signalling in colon cancer.
Yi JM, Kang TH, Han YK, Park HY, Yang JH, Bae JH, Suh JS, Kim TJ, Kim JG, Cui YH, Suzuki H, Kumegawa K, Kim SJ, Zhao Y, Park IJ, Hong SM, Chung JY, Lee SJ. Yi JM, et al. EMBO Rep. 2023 Aug 3;24(8):e56335. doi: 10.15252/embr.202256335. Epub 2023 Jun 21. EMBO Rep. 2023. PMID: 37341560 Free PMC article. - Identification of a Transmembrane Protein Involved in Shear Stress Signaling and Hepatocarcinogenesis After a Sustained Virological Response to Hepatitis C Virus.
Nishikawa M, Okada H, Kawaguchi K, Shimakami T, Nio K, Arai K, Yamashita T, Sasaki M, Kaneko S, Yamashita T, Honda M. Nishikawa M, et al. Cell Mol Gastroenterol Hepatol. 2023;16(2):263-286. doi: 10.1016/j.jcmgh.2023.04.006. Epub 2023 May 3. Cell Mol Gastroenterol Hepatol. 2023. PMID: 37146715 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases